Senti Biosciences Inc. (SNTI) is destined for greater heights as its last quarter sales were 940 K

A new trading day began on November 20, 2023, with Senti Biosciences Inc. (NASDAQ: SNTI) stock priced at $0.39, down -9.42% from the previous day of trading. During the day, the shares moved up to $0.40 and dropped to $0.3384 before settling in for the closing price of $0.40. SNTI’s price has ranged from $0.27 to $2.53 over the past 52 weeks.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


A company in the Healthcare sector has jumped its sales by 55.23% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 21.52%. With a float of $26.25 million, this company’s outstanding shares have now reached $44.06 million.

In an organization with 122 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +8.54, operating margin of -1647.90, and the pretax margin is -1358.14.

Senti Biosciences Inc. (SNTI) Insider Updates

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Senti Biosciences Inc. is 41.06%, while institutional ownership is 16.73%.

Senti Biosciences Inc. (SNTI) Performance Highlights and Predictions

In its latest quarterly report, released on 9/29/2023, the company reported earnings of $0.24 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -1358.14 while generating a return on equity of -33.42. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 21.52% per share during the next fiscal year.

Senti Biosciences Inc. (NASDAQ: SNTI) Trading Performance Indicators

Here are Senti Biosciences Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.20.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.60, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.72 in one year’s time.

Technical Analysis of Senti Biosciences Inc. (SNTI)

Let’s dig in a bit further. During the last 5-days, its volume was 1.01 million. That was better than the volume of 0.8 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 16.52%. Additionally, its Average True Range was 0.09.

During the past 100 days, Senti Biosciences Inc.’s (SNTI) raw stochastic average was set at 11.53%, which indicates a significant decrease from 16.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 314.88% in the past 14 days, which was higher than the 153.13% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.4000, while its 200-day Moving Average is $0.8615. However, in the short run, Senti Biosciences Inc.’s stock first resistance to watch stands at $0.3969. Second resistance stands at $0.4293. The third major resistance level sits at $0.4585. If the price goes on to break the first support level at $0.3353, it is likely to go to the next support level at $0.3061. Assuming the price breaks the second support level, the third support level stands at $0.2737.

Senti Biosciences Inc. (NASDAQ: SNTI) Key Stats

With a market capitalization of 16.24 million, the company has a total of 44,545K Shares Outstanding. Currently, annual sales are 4,290 K while annual income is -58,210 K. The company’s previous quarter sales were 940 K while its latest quarter income was -18,700 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Investors finally get a glimpse of Avid Bioservices Inc (CDMO) volume hitting the figure of 1.52 million.

Avid Bioservices Inc (NASDAQ: CDMO) on November 27, 2023, started off the session at the price of $5.48, plunging -13.21% from the previous trading...

Alamos Gold Inc. (AGI) volume exceeds 4.59 million: A new investment opportunity for investors

November 27, 2023, Alamos Gold Inc. (NYSE: AGI) trading session started at the price of $13.90, that was 2.70% jump from the session before....

Gracell Biotechnologies Inc ADR (GRCL) volume exceeds 0.6 million: A new investment opportunity for investors

On November 27, 2023, Gracell Biotechnologies Inc ADR (NASDAQ: GRCL) opened at $5.00, higher 6.93% from the last session. During the day, the shares...


Please enter your comment!
Please enter your name here